Cargando…
MON-163 A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of a Selective Glucocorticoid Receptor Modulator, Relacorilant, in Patients with Autonomous Cortisol Secretion Due to Cortisol-Secreting Adrenal Adenoma(s)/Hyperplasia
Relacorilant is a highly selective glucocorticoid receptor antagonist that modulates the effects of excess cortisol without interacting with the mineralocorticoid or progesterone receptor. A Phase 2 relacorilant study in patients with endogenous Cushing syndrome (CS) demonstrated improvements in gly...
Autores principales: | Auchus, Richard Joseph, Grauer, Andreas, Moraitis, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208039/ http://dx.doi.org/10.1210/jendso/bvaa046.1409 |
Ejemplares similares
-
SUN-372 A Case of Adrenal Adenoma Co-Secreting Aldosterone and Cortisol: Limits of Adrenal Vein Sampling
por: Reddy, Ramadurgam Poliki Monica, et al.
Publicado: (2019) -
Androgen Secreting Adenoma Co- Secreting Cortisol First Diagnosed During Pregnancy
por: Al Ghareeb, Zahra, et al.
Publicado: (2021) -
ODP650 Impaired Cognition in Patients with Mild Autonomous Cortisol Secretion
por: Nathani, Rohit, et al.
Publicado: (2022) -
Impaired Muscle Strength and Performance in Patients With Mild Autonomous Cortisol Secretion
por: Zhang, Catherine D, et al.
Publicado: (2021) -
Relacorilant With Pembrolizumab: A Phase 1b, Open-Label Study of a Selective Glucocorticoid Receptor Modulator Combined With a Checkpoint Inhibitor for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production
por: Habra, Mouhammed Amir, et al.
Publicado: (2021)